Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Killingberg KT"'
Autor:
Levin N; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, NTNU, Trondheim, Norway; Department of Oncology, St. Olavs Hospital, Trondheim, Norway. Electronic address: nina.levin@ntnu.no., Killingberg KT; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, NTNU, Trondheim, Norway; Department of Oncology, St. Olavs Hospital, Trondheim, Norway., Halvorsen TO; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, NTNU, Trondheim, Norway; Department of Oncology, St. Olavs Hospital, Trondheim, Norway., Danielsen S; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, NTNU, Trondheim, Norway; Department of Oncology, St. Olavs Hospital, Trondheim, Norway; Department of Physics, Norwegian University of Science and Technology, NTNU, Trondheim, Norway., Grønberg BH; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, NTNU, Trondheim, Norway; Department of Oncology, St. Olavs Hospital, Trondheim, Norway.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Oct 01; Vol. 120 (2), pp. 332-342. Date of Electronic Publication: 2024 Apr 05.
Autor:
Graabak G; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St Olav's Hospital, Trondheim University Hospital, Trondheim, Norway., Grønberg BH; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St Olav's Hospital, Trondheim University Hospital, Trondheim, Norway., Killingberg KT; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St Olav's Hospital, Trondheim University Hospital, Trondheim, Norway., Halvorsen TO; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.
Publikováno v:
JTO clinical and research reports [JTO Clin Res Rep] 2024 May 16; Vol. 5 (9), pp. 100688. Date of Electronic Publication: 2024 May 16 (Print Publication: 2024).
Autor:
Killingberg KT; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway. Electronic address: Kristin.T.Killingberg@ntnu.no., Grønberg BH; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Slaaen M; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; The Research Centre for Age-related Functional Decline and Disease (AFS), Innlandet Hospital Trust, Ottestad, Norway., Kirkevold Ø; The Research Centre for Age-related Functional Decline and Disease (AFS), Innlandet Hospital Trust, Ottestad, Norway; The Norwegian National Centre for Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway; Department of Health Science in Gjøvik, Norwegian University of Science and Technology (NTNU), Gjøvik, Norway., Halvorsen TO; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2023 Jun; Vol. 18 (6), pp. 803-812. Date of Electronic Publication: 2023 Jan 27.
Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC.
Autor:
Stokke K; Department of Clinical and Molecular Medicine, NTNU-Norwegian University of Science and Technology, N-7491 Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, N-7006 Trondheim, Norway., Halvorsen TO; Department of Clinical and Molecular Medicine, NTNU-Norwegian University of Science and Technology, N-7491 Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, N-7006 Trondheim, Norway., Grønberg BH; Department of Clinical and Molecular Medicine, NTNU-Norwegian University of Science and Technology, N-7491 Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, N-7006 Trondheim, Norway., Saltvedt I; Department of Geriatrics, St. Olavs Hospital, Trondheim University Hospital, N-7006 Trondheim, Norway.; Department of Neuro Medicine and Movement Science, NTNU-Norwegian University of Science and Technology, N-7491 Trondheim, Norway., Slaaen M; The Research Centre for Age Related Functional Decline and Diseases, Innlandet Hospital Trust, P.O. Box 68, N-2313 Ottestad, Norway.; Institute of Clinical Medicine, University of Oslo, N-0318 Oslo, Norway., Kirkevold Ø; The Research Centre for Age Related Functional Decline and Diseases, Innlandet Hospital Trust, P.O. Box 68, N-2313 Ottestad, Norway.; The Norwegian National Centre for Ageing and Health, Vestfold Hospital Trust, N-3103 Tønsberg, Norway.; Department of Health Science in Gjøvik, NTNU-Norwegian University of Science and Technology, N-2802 Gjøvik, Norway., Killingberg KT; Department of Clinical and Molecular Medicine, NTNU-Norwegian University of Science and Technology, N-7491 Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, N-7006 Trondheim, Norway., Sandvei MS; Department of Clinical and Molecular Medicine, NTNU-Norwegian University of Science and Technology, N-7491 Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, N-7006 Trondheim, Norway.
Publikováno v:
Healthcare (Basel, Switzerland) [Healthcare (Basel)] 2022 May 17; Vol. 10 (5). Date of Electronic Publication: 2022 May 17.
Autor:
Killingberg KT; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway. Electronic address: Kristin.T.Killingberg@ntnu.no., Halvorsen TO; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Fløtten Ø; Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway., Brustugun OT; Section of Oncology, Drammen Hospital, Vestre Viken Health Trust, Drammen, Norway., Langer SW; Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Denmark., Nyman J; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden; Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Hornslien K; Department of Oncology, Oslo University Hospital, Oslo, Norway., Madebo T; Department of Pulmonary Medicine, Stavanger University Hospital, Stavanger, Norway., Schytte T; Department of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Risum S; Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Denmark., Tsakonas G; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden., Engleson J; Department of Oncology, Skåne University Hospital, Lund, Sweden., Grønberg BH; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2022 Apr; Vol. 166, pp. 49-57. Date of Electronic Publication: 2022 Feb 08.
Autor:
Stokke K; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; The Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Sandvei MS; The Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Public Health and Nursing, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Grønberg BH; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; The Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Slaaen M; Research Centre for Age-related Functional Decline and Disease (AFS), Innlandet Hospital Trust HF, Hamar, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Killingberg KT; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; The Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Halvorsen TO; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; The Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Publikováno v:
Clinical Medicine Insights. Oncology [Clin Med Insights Oncol] 2022 Mar 22; Vol. 16, pp. 11795549221086578. Date of Electronic Publication: 2022 Mar 22 (Print Publication: 2022).
Autor:
Grønberg BH; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway; Department of Oncology, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway. Electronic address: bjorn.h.gronberg@ntnu.no., Killingberg KT; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway; Department of Oncology, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Fløtten Ø; Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway., Brustugun OT; Section of Oncology, Drammen Hospital, Vestre Viken Health Trust, Drammen, Norway., Hornslien K; Department of Oncology, Oslo University Hospital, Oslo, Norway., Madebo T; Department of Pulmonary Medicine, Stavanger University Hospital, Stavanger, Norway., Langer SW; Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Denmark., Schytte T; Department of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Nyman J; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden; Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Risum S; Department of Oncology, Rigshospitalet, Copenhagen, Denmark., Tsakonas G; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden., Engleson J; Department of Oncology, Skåne University Hospital, Lund, Sweden., Halvorsen TO; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway; Department of Oncology, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2021 Mar; Vol. 22 (3), pp. 321-331.
Autor:
Halvorsen TO; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Stokke K; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Killingberg KT; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Raj SX; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Sørhaug S; Department of Thoracic Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Brustugun OT; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Fløtten Ø; Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway., Helbekkmo N; Department of Pulmonology, University Hospital of North Norway, Tromsø, Norway., Hornslien K; Department of Oncology, Oslo University Hospital, Oslo, Norway., Madebo T; Department of Pulmonary Medicine, Stavanger University Hospital, Stavanger, Norway., Fluge S; Department of Pulmonary Medicine, Haugesund Hospital, Haugesund, Norway., Grønberg BH; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Publikováno v:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2020 Sep; Vol. 59 (9), pp. 1051-1057. Date of Electronic Publication: 2020 Jun 16.